Last week, LiVDerm faculty member Dr. Pariser was named by Vial as a member of their Scientific Advisory Board. Launched in January 2022, the Vial Dermatology Contract Research Organization is designed to deliver faster execution and higher quality results in dermatology clinical trials. As former president of the American Academy of Dermatology and senior physician at Pariser Dermatology Specialists, Dr. Pariser brings more than 40 years of experience in clinical strategy and trial design to his new role at Vial. Regarding his new appointment, Dr. Pariser says, “I am excited to support the Vial team, along with their sponsors, as they utilize technology to advance the field of dermatology research.”
About Dr. Pariser
David M. Pariser, MD, is board-certified by the American Board of Dermatology and the American Board of Pathology with a special competence in dermatopathology. He is recognized worldwide for his clinical and research expertise in psoriasis, atopic dermatitis, hyperhidrosis, cutaneous oncology, and many other skin conditions. Throughout his four-decade dermatology career, he has lectured internationally and published extensively on his research and clinical insights.
Dr. Pariser has been a longtime faculty of LiVDerm’s South Beach Symposium (SBS), taking part in the Expert Psoriasis Panel at the 2009 SBS. More recently, he took part in the 15th Annual SBS in 2017 and the 17th Annual SBS in 2019, using the platform to share his insights on conditions including hyperhidrosis, a topic on which he is a renowned expert.
About Vial
Vial’s mission is to bring new therapies to market more quickly than the current pace by fostering clinical trials with faster execution and higher quality. Based in San Francisco, California Vial has over 70 employees and more than 250 dermatologist partners supporting their research teams; these partnerships have resulted in a network of over 35 Dermatology Clinics in which trials are being conducted. The network of Vial partners and clinics has contributed to over 150 drug trials for many of the leading sponsors in dermatology, for indications including atopic dermatitis, psoriasis, vitiligo, alopecia areata, rosacea, hidradenitis suppurativa, prurigo nodularis, as well as many aesthetic dermatology indications. The clinic network runs trials from phase I through phase IV.
Vial Dermatology CRO
Per the Vial website, a Contract Research Organization (CRO) provides sponsors such as pharmaceutical, biotech, and medical device companies with research management services. Traditional CROs provide clinical trial management services, while laboratory CROs provide drug discovery, manufacturing, laboratory, and bioanalytical services. Typically, sponsors outsource these services to save resources on the development of their new drugs.
In the late 1970s and early 1980s, when CROs were first formed, they specialized in a particular service, such as data management and statistical services, regulatory support, or clinical research monitoring. Today, most CROs are full-service, providing complete clinical trial management support. As a Vial Dermatology CRO Scientific Advisory Board member, Dr. Pariser will serve as a key opinion leader to inform sponsors’ clinical strategies, regulatory guidelines, trial design and participant selection.
LiVDerm extends our congratulations to Dr. Pariser on this career honor, and thanks him for being a longstanding SBS faculty member and for his unparalleled contributions to the field of dermatology.
Sources:
